BIO-TECHNE Corp — Director's Dealing 2020

May 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2020-05-06

Reporting Person: WIENS HAROLD J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-06	Common Stock	M	4260.00	$87.34	Acquired	9481.00	Direct
2020-05-06	Common Stock	S	4260.00	$250.00	Disposed	5221.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-06	Stock Option (right to buy)	$87.34	M	4260.00	Disposed	2025-10-28	Common Stock (4260.00)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$101.19	2026-10-26	Common Stock (3985.00)	3985.00	Direct
Stock Option (right to buy)	$125.05	2027-10-26	Common Stock (3125.00)	3125.00	Direct
Stock Option (right to buy)	$179.84	2028-10-25	Common Stock (1898.00)	1898.00	Direct
Stock Option (right to buy)	$201.64	2029-10-24	Common Stock (2011.00)	2011.00	Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 31, 2019.

F2: The option vests on the earlier of the one year anniversary of the grant date (10/24/2019) or the date of Bio-Techne 2020 annual meeting of shareholders.